SOX2 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), downregulation of CHEK1 by silencing LINC01224 or elevating miR-330-5p could inhibit stemness, by reducing the expression of CSC biomarkers (OCT4, CD133 and SOX2) [47].